Cited by 961Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchExtracellular vesicles in disease

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case‐control study

Open access

Fiandaca, Massimo S., Kapogiannis, Dimitrios, Mapstone, Mark, Boxer, Adam, Eitan, Erez, Schwartz, Janice B., Abner, Erin L., Petersen, Ronald C., Federoff, Howard J., Miller, Bruce L., Goetzl, Edward J.·2015·Alzheimer's & Dementia

DOI 10.1016/j.jalz.2014.06.008PMC PMC4329112

Open this paper in CoChat — free account

Abstract

Background: Proteins pathogenic in Alzheimer's disease (AD) were extracted from neurally derived blood exosomes and quantified to develop biomarkers for the staging of sporadic AD. Methods: Blood exosomes obtained at one time‐point from patients with AD (n = 57) or frontotemporal dementia (FTD) (n = 16), and at two time‐points from others (n = 24) when cognitively normal and 1 to 10 years later when diagnosed with AD were enriched for neural sources by immunoabsorption. AD‐pathogenic exosomal proteins were extracted and quantified by enzyme‐linked immunosorbent assays. Results: Mean exosomal levels of total tau, P‐T181‐tau, P‐S396‐tau, and amyloid β 1–42 (Aβ1–42) for AD and levels of P‐T181‐tau and Aβ1–42 for FTD were significantly higher than for case‐controls. Step‐wise discriminant modeling incorporated P‐T181‐tau, P‐S396‐tau, and Aβ1–42 in AD, but only P‐T181‐tau in FTD. Classification of 96.4% of AD patients and 87.5% of FTD patients was correct. In 24 AD patients, exosomal levels of P‐S396‐tau, P‐T181‐tau, and Aβ1–42 were significantly higher than for controls both 1 to 10 years before and when diagnosed with AD. Conclusions: Levels of P‐S396‐tau, P‐T181‐tau, and Aβ1–42 in extracts of neurally derived blood exosomes predict the development of AD up to 10 years before clinical onset.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2014.06.008

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221
Self-citation
Classification of primary progressive aphasia and its variants
Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., Ogar, J. M., Rohrer, J. D., Black, S., Boeve, B. F., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31821103e6 · Cited by 5,141
Self-citation
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
Dubois, B., Feldman, H. H., Jacova, C., DeKosky, S. T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70178-3 · Cited by 4,411
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
Villemagne, V. L., Burnham, S., Bourgeat, P., Brown, B., Ellis, K. A., Salvado, O., Szoeke, C., Macaulay, S. L., Martins, R., Maruff, P., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70044-9 · Cited by 2,279
Alzheimer’s Dementia
Melnick, V. L., & Dubler, N. N. (1985) · Contemporary Issues in Biomedicine, Ethics, and Society · doi:10.1007/978-1-4612-5174-3 · Cited by 1,986
Alzheimer’s disease β-amyloid peptides are released in association with exosomes
Rajendran, L., Honsho, M., Zahn, T. R., Keller, P., Geiger, K. D., Verkade, P., & Simons, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603838103 · Cited by 1,343
Plasma phospholipids identify antecedent memory impairment in older adults
Mapstone, M. E., Cheema, A. K., Fiandaca, M. S., Zhong, X., Mhyre, T. R., MacArthur, L. H., Hall, W. J., Fisher, S. G., Peterson, D. R., Haley, J. M., et al. (2014) · Nature Medicine · doi:10.1038/nm.3466 · Cited by 1,060
Self-citation
Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease
Saman, S., Kim, W., Raya, M., Visnick, Y., Miro, S., Saman, S., Jackson, B., McKee, A. C., Alvarez, V. E., Lee, N. C. Y., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.277061 · Cited by 985

Show all 31 references

Sorted by citations

Items 401–500 of 961

Identification of amyloid beta in small extracellular vesicles via Raman spectroscopy
Imanbekova, M., Suarasan, S., Rojalin, T., Mizenko, R. R., Hilt, S., Mathur, M., Lépine, P., Nicouleau, M., Mohamed, N., Durcan, T. M., et al. (2021) · Nanoscale Advances · doi:10.1039/d1na00330e · Cited by 38
Brain-Derived Exosomal Proteins as Effective Biomarkers for Alzheimer’s Disease: A Systematic Review and Meta-Analysis
Kim, K. Y., Shin, K. Y., & Chang, K. (2021) · Biomolecules · doi:10.3390/biom11070980 · Cited by 36
Multiple Sclerosis: Focus on Extracellular and Artificial Vesicles, Nanoparticles as Potential Therapeutic Approaches
Nuzzo, D., & Picone, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168866 · Cited by 36
Long-Term Effects of SARS-CoV-2 in the Brain: Clinical Consequences and Molecular Mechanisms
Granholm, A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093190 · Cited by 37
Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer’s disease mouse model
Tallon, C., Bell, B. J., Malvankar, M. M., Deme, P., Nogueras‐Ortiz, C. J., Eren, E., Thomas, A. G., Hollinger, K. R., Pal, A., Mustapić, M., et al. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00383-9 · Cited by 35
Self-citation
Lipidomic Analysis of Plasma Extracellular Vesicles Derived from Alzheimer’s Disease Patients
Krokidis, M. G., Pucha, K. A., Mustapić, M., Exarchos, T. P., Vlamos, P., & Kapogiannis, D. (2024) · Cells · doi:10.3390/cells13080702 · Cited by 34
Self-citation
Does traumatic brain injury hold the key to the Alzheimer's disease puzzle?
Becker, R. E., Kapogiannis, D., & Greig, N. H. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.11.007 · Cited by 34
Self-citation
Exosome Circuitry During (De)(Re)Myelination of the Central Nervous System
Domingues, H. S., Falcão, A. M., Pinto, I. M., Salgado, A. J., & Teixeira, F. G. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00483 · Cited by 35
Exosomes as drug delivery vehicles and biomarkers for neurological and auditory systems
Mittal, R., Bencie, N., Langlie, J. A., Mittal, J., & Eshraghi, A. A. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30484 · Cited by 36
Extracellular vesicles in pharmacology: Novel approaches in diagnostics and therapy
Quadri, Z., Elsherbini, A. M., & Bieberich, E. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105980 · Cited by 37
A Search for Blood Biomarkers for Autism: Peptoids
Zaman, S., Yazdani, U., Deng, Y., Li, W., Gadad, B. S., Hynan, L., Karp, D., Roatch, N., Schutte, C., Nathan Marti, C., et al. (2016) · Scientific Reports · doi:10.1038/srep19164 · Cited by 33
Surface protein profiling and subtyping of extracellular vesicles in body fluids reveals non‐CSF biomarkers of Alzheimer's disease
Cai, Y., Chen, T., Cai, Y., Liu, J., Yu, B., Fan, Y., Su, J., Zeng, Y., Xiao, X., Ren, L., et al. (2024) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12432 · Cited by 36
Mesenchymal Stem Cell-Derived Exosomes as a Neuroregeneration Treatment for Alzheimer’s Disease
Shah, S., Mansour, H. M., Aguilar, T. M., & Lucke-Wold, B. P. (2024) · Biomedicines · doi:10.3390/biomedicines12092113 · Cited by 37
Endothelial‐derived plasma exosome proteins in Alzheimer’s disease angiopathy
Abner, E. L., Elahi, F. M., Jicha, G. A., Mustapić, M., Al‐Janabi, O. M., Kramer, J. H., Kapogiannis, D., & Goetzl, E. J. (2020) · The FASEB Journal · doi:10.1096/fj.202000034r · Cited by 34
Self-citation
Exosome-Mediated Genetic Information Transfer, a Missing Piece of Osteoblast–Osteoclast Communication Puzzle
Yin, P., Lv, H., Li, Y., Deng, Y., Zhang, L., & Tang, P. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00336 · Cited by 33
Role of Exosomes in the Pathogenesis and Theranostic of Alzheimer’s Disease and Parkinson’s Disease
He, A., Wang, M., Li, X., Chen, H., Lim, K., Lu, L., & Zhang, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311054 · Cited by 34
Endo-lysosomal dysfunction in neurodegenerative diseases: opinion on current progress and future direction in the use of exosomes as biomarkers
Herman, M., Randall, G. W., Spiegel, J. L., Maldonado, D. J., & Simoes, S. (2024) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2022.0387 · Cited by 32
Increased Levels of Extracellular Microvesicle Markers and Decreased Levels of Endocytic/Exocytic Proteins in the Alzheimer’s Disease Brain
Musunuri, S., Khoonsari, P. E., Mikus, M. S., Wetterhall, M., Månberg, A., Lannfelt, L., Erlandsson, A., Bergquist, J., Ingelsson, M., Shevchenko, G., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160271 · Cited by 34
Detection of the receptor for advanced glycation endproducts in neuronally-derived exosomes in plasma
Patterson, S. A., Deep, G., & Brinkley, T. E. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.04.181 · Cited by 32
miRNA 933 Expression by Endothelial Cells is Increased by 27-Hydroxycholesterol and is More Prevalent in Plasma from Dementia Patients
Dias, I. H. K., Brown, C. L., Shabir, K., Polidori, M. C., & Griffiths, H. R. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180201 · Cited by 32
Melatonin affects the release of exosomes and tau-content in in vitro amyloid-beta toxicity model
Ozansoy, M., Ozansoy, M. B., Yuluğ, B., Çankaya, Ş., Kılıç, E., Goktekin, S., & Kılıç, Ü. (2020) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2019.11.046 · Cited by 32
Alzheimer’s disease: phenotypic approaches using disease models and the targeting of tau protein
Lauretti, E., & Praticò, D. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1737012 · Cited by 34
Dual Neutral Sphingomyelinase-2/Acetylcholinesterase Inhibitors for the Treatment of Alzheimer’s Disease
Bilousova, T. V., Simmons, B. J., Knapp, R. R., Elias, C. J., Campagna, J. J., Melnik, M., Chandra, S., Focht, S., Zhu, C., Vadivel, K., et al. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00311 · Cited by 34
Extracellular RNA in aging
Dluzen, D. F., Noren Hooten, N., & Evans, M. K. (2017) · WIREs RNA · doi:10.1002/wrna.1385 · Cited by 31
Microglial autophagy in Alzheimer’s disease and Parkinson’s disease
Wang, Z., Wang, Q., Li, S., Li, X.-J., Yang, W., & He, D. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1065183 · Cited by 35
A critical appraisal of blood-based biomarkers for Alzheimer’s disease
Lista, S., Mapstone, M. E., Caraci, F., Emanuele, E., López‐Ortiz, S., Martín-Hernández, J., Triaca, V., Imbimbo, C., Gabelle, A., Mielke, M. M., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102290 · Cited by 30
Self-citation
CNS cell-derived exosome signatures as blood-based biomarkers of neurodegenerative diseases
Park, C., Weerakkody, J. S., Schneider, R., Miao, S., & Pitt, D. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1426700 · Cited by 35
TAF1 Transcripts and Neurofilament Light Chain as Biomarkers for X‐linked Dystonia‐Parkinsonism
Ali, J. A., Vaine, C. A., Shah, S., Campion, L. N., Hakoum, A., Supnet, M. L., Acuña, P. J., Aldykiewicz, G., Multhaupt‐Buell, T., Ganza-Bautista, N. G., et al. (2020) · Movement Disorders · doi:10.1002/mds.28305 · Cited by 28
Biophotonics for diagnostic detection of extracellular vesicles
Gualerzi, A., Picciolini, S., Carlomagno, C., Rodà, F., & Bedoni, M. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.04.014 · Cited by 30
A dual-screening electrochemiluminescent aptasensor based on a mesoporous silica nano-sieve for specific detection of amyloid-β monomer
Tan, R., Wang, Y., Mi, X., Li, H., & Tu, Y. (2021) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2021.131065 · Cited by 31
Extracellular Vesicles Derived From Plasma of Patients With Neurodegenerative Disease Have Common Transcriptomic Profiling
Sproviero, D., Gagliardi, S., Zucca, S., Arigoni, M., Giannini, M., Garofalo, M., Fantini, V., Pansarasa, O., Avenali, M., Ramusino, M. C., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.785741 · Cited by 31
Transcellular Spreading of Tau in Tauopathies
Demaegd, K. C., Schymkowitz, J. W. H., & Rousseau, F. (2018) · ChemBioChem · doi:10.1002/cbic.201800288 · Cited by 32
Complicated Role of Post-translational Modification and Protease-Cleaved Fragments of Tau in Alzheimer’s Disease and Other Tauopathies
Yang, J., Shen, N., Shen, J., Yang, Y., & Li, H.-L. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03867-x · Cited by 32
Emerging role of exosomes as a liquid biopsy tool for diagnosis, prognosis & monitoring treatment response of communicable & non-communicable diseases
Yadav, R., Singh, A. V., Kushwaha, S., & Chauhan, D. S. (2024) · International Journal of Microbiology Research · doi:10.4103/ijmr.ijmr_2344_22 · Cited by 33
Dual Role of Exosome in Neurodegenerative Diseases: A Review Study
Sheykhhasan, M., Heidari, F., Farsani, M. E., Azimzadeh, M., Kalhor, N., Ababzadeh, S., & Seyedebrahimi, R. (2023) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x18666230726161035 · Cited by 30
MicroRNAs in Post-traumatic Stress Disorder
Snijders, C., de Nijs, L., Baker, D. G., Hauger, R. L., van den Hove, D., Kenis, G., Nievergelt, C. M., Boks, M. P., Vermetten, E. H. G. J. M., Gage, F. H., et al. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2017_32 · Cited by 31
Extracellular Vesicles in Neurodegenerative Diseases: An Update
Sigdel, S., Swenson, S., & Wang, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713161 · Cited by 31
Blood and cerebrospinal fluid biomarkers
Kawata, K., Tierney, R., & Langford, D. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63954-7.00022-7 · Cited by 29
Biomarkers in Alzheimer’s disease
Janeiro, M. H., Ardanaz, C. G., Sola-Sevilla, N., Dong, J., Cortés-Erice, M., Solas, M., Puerta, E., & Ramírez, M. J. (2020) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2020-0090 · Cited by 37
Alzheimer's disease protease-containing plasma extracellular vesicles transfer to the hippocampus via the choroid plexus
Lee, J., Ostalecki, C., Oberstein, T. J., Schierer, S., Zinser, E., Eberhardt, M., Blume, K., Plosnita, B., Stich, L., Bruns, H., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103903 · Cited by 32
Vitamin D-binding protein in plasma microglia-derived extracellular vesicles as a potential biomarker for major depressive disorder
Zhang, G., Li, L., Kong, Y., Xu, D., Bao, Y., Zhang, Z., Liao, Z., Jiao, J., Fan, D., Long, X., et al. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.02.049 · Cited by 30
“Liquid Biopsy” of White Matter Hyperintensity in Functionally Normal Elders
Elahi, F. M., Casaletto, K. B., Altendahl, M., Staffaroni, A. M., Fletcher, E. M., Filshtein, T. J., Glymour, M. M., Miller, B. L., Hinman, J. D., DeCarli, C. S., et al. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00343 · Cited by 28
Self-citation
The interplay between aging‐associated loss of protein homeostasis and extracellular vesicles in neurodegeneration
Guix, F. X. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24526 · Cited by 30
Emerging Roles of Extracellular Vesicles in Alzheimer’s Disease: Focus on Synaptic Dysfunction and Vesicle–Neuron Interaction
Gabrielli, M., Tozzi, F., Verderio, C., & Origlia, N. (2022) · Cells · doi:10.3390/cells12010063 · Cited by 34
Elevation of astrocyte-derived extracellular vesicles over the first month post-stroke in humans
Edwardson, M. A., Mitsuhashi, M., & Epps, D. V. (2024) · Scientific Reports · doi:10.1038/s41598-024-55983-w · Cited by 28
Most recent advances and applications of extracellular vesicles in tackling neurological challenges
Kaur, M., Fusco, S., den Broek, B. V., Aseervatham, J., Rostami, A. M., Iacovitti, L., Grassi, C., Łukomska, B., & Srivastava, A. K. (2024) · Medicinal Research Reviews · doi:10.1002/med.22035 · Cited by 28
Exosome nanovesicles: biomarkers and new strategies for treatment of human diseases
Xu, C. Y., Jiang, C., Li, Z., Gao, H., Xian, J., Guo, W., He, D., Peng, X., Zhou, D., & Li, D. (2024) · MedComm · doi:10.1002/mco2.660 · Cited by 32
Detection and Isolation of Tissue‐Specific Extracellular Vesicles From the Blood
Newman, L. A., & Rowland, A. (2025) · Journal of Extracellular Biology · doi:10.1002/jex2.70059 · Cited by 28
Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer’s Disease
Robinson, R. A. S., Amin, B., & Guest, P. C. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-52479-5_2 · Cited by 29
Exosome and Biomimetic Nanoparticle Therapies for Cardiac Regenerative Medicine
Stine, S. J., Popowski, K. D., Su, T., & Cheng, K. (2020) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x15666200309143924 · Cited by 30
Plasma extracellular vesicles reveal early molecular differences in amyloid positive patients with early-onset mild cognitive impairment
Cano, A. C., Antonio, E. E., Bernuz, M., Puerta, R., García‐González, P., de Rojas, I., Olivé, C., Pérez‐Cordón, A., Montrreal, L., Núñez‐Llaves, R., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01793-7 · Cited by 30
Small Extracellular Vesicles’ miRNAs: Biomarkers and Therapeutics for Neurodegenerative Diseases
Lim, W. Q., Michelle Luk, K. H., Lee, K. Y., Nurul, N., Loh, S. J., Yeow, Z. X., Wong, Q. X., Daniel Looi, Q. H., Chong, P. P., How, C. W., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041216 · Cited by 25
A Liquid Biopsy-Based Approach to Isolate and Characterize Adipose Tissue-Derived Extracellular Vesicles from Blood
Mishra, S., Kumar, A., Kim, S., Su, Y., Singh, S., Sharma, M., Almousa, S., Rather, H., Jain, H., Lee, J., et al. (2023) · ACS Nano · doi:10.1021/acsnano.3c00422 · Cited by 29
Molecular beacon–based detection of circulating microRNA-containing extracellular vesicle as an α-synucleinopathy biomarker
Yu, Z., Zheng, Y., Cai, H., Li, S., Liu, G., Kou, W., Yang, C., Cao, S., Chen, L., Liu, X., et al. (2024) · Science Advances · doi:10.1126/sciadv.adl6442 · Cited by 29
Blood extracellular vesicles (EVs) of central nervous system origin: a window into the brain
Agliardi, C., & Clerici, M. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.264454 · Cited by 27
The long-term consequences of repetitive head impacts: Chronic traumatic encephalopathy
Alosco, M. L., & Stern, R. A. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804766-8.00018-2 · Cited by 28
The Diagnostic Value of Exosome-Derived Biomarkers in Alzheimer's Disease and Mild Cognitive Impairment: A Meta-Analysis
Xing, W., Gao, W., Lv, X., Xu, X., Zhang, Z., Yan, J., Mao, G., & Bu, Z. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.637218 · Cited by 27
Extracellular vesicles with diagnostic and therapeutic potential for prion diseases
Khadka, A., Spiers, J. G., Cheng, L., & Hill, A. F. (2022) · Cell and Tissue Research · doi:10.1007/s00441-022-03621-0 · Cited by 29
Lymphocytes, Platelets, Erythrocytes, and Exosomes as Possible Biomarkers for Alzheimer’s Disease Clinical Diagnosis
Pluta, R. M., & Ułamek-Kozioł, M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-05542-4_4 · Cited by 51
Role of endolysosomes and inter-organellar signaling in brain disease
Afghah, Z., Chen, X., & Geiger, J. D. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104670 · Cited by 27
Myeloid extracellular vesicles: messengers from the demented brain
Nigro, A., Colombo, F., Casella, G., Finardi, A., Verderio, C., & Furlan, R. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00017 · Cited by 26
Delivering synaptic protein mRNAs via extracellular vesicles ameliorates cognitive impairment in a mouse model of Alzheimer’s disease
Cai, H., Pang, Y., Ren, Z., Fu, X., & Jia, L. (2024) · BMC Medicine · doi:10.1186/s12916-024-03359-2 · Cited by 26
Exosomes for neurodegenerative diseases: diagnosis and targeted therapy
Tao, H., & Gao, B. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12329-w · Cited by 27
Exosomes in Central Nervous System Diseases: A Comprehensive Review of Emerging Research and Clinical Frontiers
Li, J., Song, J., Jia, L., Wang, M., Ji, X., Meng, R., & Zhou, D. (2024) · Biomolecules · doi:10.3390/biom14121519 · Cited by 28
Exosomal Biomarkers: A Comprehensive Overview of Diagnostic and Prognostic Applications in Malignant and Non-Malignant Disorders
Delshad, M., Sanaei, M., Mohammadi, M. H., Sadeghi, A., & Bashash, D. (2025) · Biomolecules · doi:10.3390/biom15040587 · Cited by 29
Extracellular vesicles as therapeutic modulators of neuroinflammation in Alzheimer’s disease: a focus on signaling mechanisms
Han, J., Zhang, X., Kang, L., & Guan, J. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03443-1 · Cited by 26
Fluid Candidate Biomarkers for Alzheimer’s Disease: A Precision Medicine Approach
Prete, E. D., Beatino, M. F., Campese, N., Giampietri, L., Siciliano, G., Ceravolo, R., & Baldacci, F. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10040221 · Cited by 29
Human endogenous retrovirus K (HERV-K) env in neuronal extracellular vesicles: a new biomarker of motor neuron disease
Li, Y., Chen, Y., Zhang, N., & Fan, D. (2021) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2021.1936061 · Cited by 26
Alzheimer’s-Like Pathology at the Crossroads of HIV-Associated Neurological Disorders
Chemparthy, D. T., Kannan, M., Gordon, L., Buch, S. J., & Sil, S. (2021) · Vaccines · doi:10.3390/vaccines9080930 · Cited by 27
Developing Biomarkers of Mild Traumatic Brain Injury: Promise and Progress of CNS-Derived Exosomes
Vaughn, M. N., Winston, C. N., Levin, N., Rissman, R. A., & Risbrough, V. B. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.698206 · Cited by 28
Review on the roles of specific cell-derived exosomes in Alzheimer's disease
Zou, Y., Mu, D., Ma, X., Wang, D., Zhong, J., Gao, J., Yu, S., & Qiu, L. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.936760 · Cited by 31
Manipulation of the diet–microbiota–brain axis in Alzheimer’s disease
Lee, D. D., Lee, V. M. ‐., & Hur, S. K. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1042865 · Cited by 27
Dumbbell Aptamer Sensor Based on Dual Biomarkers for Early Detection of Alzheimer’s Disease
Zhou, J., Sun, Y., Zhang, J., Luo, F., Ma, H., Guan, M., Feng, J., & Dong, X. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c21379 · Cited by 26
Altered in vivo early neurogenesis traits in patients with depression: Evidence from neuron-derived extracellular vesicles and electroconvulsive therapy
Xie, X., Xu, S., Yao, L., Chen, M., Zhang, H., Wang, C., Nagy, C., & Liu, Z. (2023) · Brain stimulation · doi:10.1016/j.brs.2023.12.006 · Cited by 31
Plasma versus serum for extracellular vesicle (EV) isolation: A duel for reproducibility and accuracy for CNS‐originating EVs biomarker analysis
Taha, H. B. (2023) · Journal of Neuroscience Research · doi:10.1002/jnr.25231 · Cited by 25
Proteomics of plasma-derived extracellular vesicles reveals S100A8 as a novel biomarker for Alzheimer's disease: A preliminary study
Zhang, Y., Yuan, Z. K., Zhang, J., Gao, Y., Gao, X., Li, S., Cui, C., & Yang, G. (2024) · Journal of Proteomics · doi:10.1016/j.jprot.2024.105279 · Cited by 26
HSV-1 infection induces phosphorylated tau propagation among neurons via extracellular vesicles
Protto, V., Miteva, M. T., Iannuzzi, F., Marcocci, M. E., Puma, D. D. L., Piacentini, R., Belli, M., Sansone, L., Pietrantoni, A., Grassi, C., et al. (2024) · mBio · doi:10.1128/mbio.01522-24 · Cited by 26
Roles, Functions, and Pathological Implications of Exosomes in the Central Nervous System
Spinelli, S., Tripodi, D., Corti, N., Zocchi, E., Bruschi, M., Leoni, V., & Dominici, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031345 · Cited by 28
Exosomes as Therapeutic and Diagnostic Tools: Advances, Challenges, and Future Directions
Jangam, T. C., Desai, S. A., Patel, V. P., Pagare, N. B., & Raut, N. D. (2025) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-025-01730-5 · Cited by 26
A hypothesis-generating scoping review of miRs identified in both multiple sclerosis and dementia, their protein targets, and miR signaling pathways
Varma-Doyle, A. V., Lukiw, W. J., Zhao, Y., Lovera, J. F., & Devier, D. J. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117202 · Cited by 26
Cerebrospinal Fluid of Patients With Alzheimer’s Disease Contains Increased Percentages of Synaptophysin-Bearing Microvesicles
Utz, J., Berner, J., Munoz, L. E., Oberstein, T. J., Kornhuber, J., i, M. H., Maler, J. M., & Spitzer, P. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.682115 · Cited by 25
Structure and function of glycosphingolipids on small extracellular vesicles
He, X. H., Guan, F., & Lei, L. (2022) · Glycoconjugate Journal · doi:10.1007/s10719-022-10052-0 · Cited by 27
Comparative assessment of Alzheimer’s disease-related biomarkers in plasma and neuron-derived extracellular vesicles: a nested case-control study
Manolopoulos, A., Delgado‐Peraza, F., Mustapić, M., Pucha, K. A., Nogueras‐Ortiz, C. J., Daskalopoulos, A., Knight, D. D., Leoutsakos, J., Oh, E. S., Lyketsos, C. G., et al. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1254834 · Cited by 26
Self-citation
The fluorescent ligand bTVBT2 reveals increased p-tau uptake by retinal microglia in Alzheimer’s disease patients and AppNL−F/NL−F mice
Nuñez‐Diaz, C., Andersson, E., Schultz, N., Pocevičiūtė, D., Hansson, O., Bank, T. N. B., Nilsson, K. P. R., & Wennström, M. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01375-7 · Cited by 24
Neuron‐derived extracellular vesicles as a liquid biopsy for brain insulin dysregulation in Alzheimer's disease and related disorders
Cleary, J. A., Kumar, A., Craft, S., & Deep, G. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14497 · Cited by 25
Advanced biomarkers: Beyond amyloid and tau: Emerging non-traditional biomarkers for alzheimer`s diagnosis and progression
Afrin, M. R., Upadhyaya, P. G., Hashim, A., Bhattacharya, K., Chanu, N. R., Das, D., Khanal, P., & Deka, S. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102736 · Cited by 27
Biosensor-based methods for exosome detection with applications to disease diagnosis
Ge, W., Mu, Z., Yang, S., Zeng, Y., Deng, Y., Lin, Y., Xie, P., & Li, G. (2025) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2025.117362 · Cited by 26
Transmissible Endosomal Intoxication: A Balance between Exosomes and Lysosomes at the Basis of Intercellular Amyloid Propagation
Bécot, A., Volgers, C., & van Niel, G. (2020) · Biomedicines · doi:10.3390/biomedicines8080272 · Cited by 25
Profiling Inflammatory Extracellular Vesicles in Plasma and Cerebrospinal Fluid: An Optimized Diagnostic Model for Parkinson’s Disease
Vacchi, E., Burrello, J., Burrello, A., Bolis, S., Monticone, S., Barile, L., Kaelin‐Lang, A., & Melli, G. (2021) · Biomedicines · doi:10.3390/biomedicines9030230 · Cited by 24
Zebrafish as a preclinical model for Extracellular Vesicle-based therapeutic development
Androuin, A., Verweij, F. J., & van Niel, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.025 · Cited by 25
Evaluation of blood‐based, extracellular vesicles as biomarkers for aging‐related TDP‐43 pathology
Winston, C. N., Sukreet, S., Lynch, H. M., Lee, V. M. ‐., Wilcock, D. M., Nelson, P. T., & Rissman, R. A. (2022) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12365 · Cited by 23
Smart Nanoscale Extracellular Vesicles in the Brain: Unveiling their Biology, Diagnostic Potential, and Therapeutic Applications
Onkar, A., Khan, F., Goenka, A., Rajendran, R. L., Dmello, C., Hong, C. M., Mubin, N., Gangadaran, P., & Ahn, B. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c16839 · Cited by 25
Genetic effect of interleukin-1 beta (C-511T) polymorphism on the structural covariance network and white matter integrity in Alzheimer’s disease
Huang, C., Hsu, S., Tsai, S., Chen, N.-C., Liu, M., Lee, C., Huang, S., Chang, W.-N., Chang, Y., Tsai, W., et al. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0791-z · Cited by 23
Exosomes as Possible Spread Factor and Potential Biomarkers in Alzheimer'S Disease: Current Concepts
Pluta, R. M., Ułamek-Kozioł, M., Januszewski, S., & Czuczwar, S. J. (2018) · Biomarkers in Medicine · doi:10.2217/bmm-2018-0034 · Cited by 25
Extracellular vesicles reveal abnormalities in neuronal iron metabolism in restless legs syndrome
Chawla, S., Gulyani, S., Allen, R. P., Earley, C. J., Li, X., van Zijl, P. C. M., & Kapogiannis, D. (2019) · SLEEP · doi:10.1093/sleep/zsz079 · Cited by 24
Self-citation
Assessment of technical and clinical utility of a bead-based flow cytometry platform for multiparametric phenotyping of CNS-derived extracellular vesicles
Brahmer, A., Geiß, C., Lygeraki, A., Neuberger, E. W. I., Tzaridis, T., Nguyen, T. T., Luessi, F., Régnier‐Vigouroux, A., Hartmann, G., Simon, P. D., et al. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01308-9 · Cited by 26
Exosomes in Clinical Laboratory: From Biomarker Discovery to Diagnostic Implementation
Aljohani, M. A. (2025) · Medicina · doi:10.3390/medicina61111930 · Cited by 24
Utility of Animal Models to Understand Human Alzheimer’s Disease, Using the Mastermind Research Approach to Avoid Unnecessary Further Sacrifices of Animals
Qin, T., Prins, S., Groeneveld, G. J., van Westen, G. J. P., de Vries, H. E., Wong, Y. C., Bischoff, L. J. M., & de Lange, E. C. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093158 · Cited by 24
Modulation of Amyloid-β and Tau in Alzheimer’s Disease Plasma Neuronal-Derived Extracellular Vesicles by Cerebrolysin® and Donepezil
Alvarez, X. A., Winston, C. N., Barlow, J. W., Sarsoza, F. M., Álvarez, I., Aleixandre, M., Linares, C., García-Fantini, M., Kastberger, B., Winter, S., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220575 · Cited by 23
Circulating brain-derived extracellular vesicles expressing neuroinflammatory markers are associated with HIV-related neurocognitive impairment
de Menezes, E. G. M., Liu, J. S., Bowler, S. A., Giron, L. B., D’Antoni, M. L., Shikuma, C. M., Abdel‐Mohsen, M., Ndhlovu, L. C., & Norris, P. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1033712 · Cited by 23

Authors: Fiandaca, M. S., Kapogiannis, D., Mapstone, M., Boxer, A., Eitan, E., Schwartz, J. B., Abner, E. L., Petersen, R. C., Federoff, H. J., Miller, B. L., & Goetzl, E. J.
Affiliations: Georgetown University Medical Center (US)
National Institute on Aging (US)
University of Rochester Medicine (US)
University of California San Francisco Medical Center (US)
University of Kentucky (US)
Mayo Clinic (US)
Corresponding author: Goetzl, Edward J.
ORCID: Fiandaca, Massimo S.
Kapogiannis, Dimitrios
Mapstone, Mark
Boxer, Adam
Eitan, Erez
Schwartz, Janice B.
Abner, Erin L.
Petersen, Ronald C.
Federoff, Howard J.
Miller, Bruce L.
Goetzl, Edward J.
Venue: Alzheimer's & Dementia
Publisher: Wiley
Published: 2014-08-14
Volume: 11
Issue: 6
Pages: 600
ISSN: 1552-5260 (ISSN-L)
1552-5279
DOI: 10.1016/j.jalz.2014.06.008
PMC: PMC4329112
OpenAlex: W1995903088
Cited by: 959
References: 31
Citations by year: 2026: 77 · 2025: 91 · 2024: 109 · 2023: 86 · 2022: 115 · 2021: 106 · 2020: 105 · 2019: 93 · 2018: 46 · 2017: 50 · 2016: 50 · 2015: 24 · 2014: 3
FWCI: 28.15
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Alzheimer s & Dementia (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
eScholarship (California Digital Library) (submittedVersion)
Funders: National Institute on Aging (NIA RO1AG030753)
National Institutes of Health (UK ADC P30 AG028383)
Genentech
Alzheimer's Association
Association for Frontotemporal Degeneration
Alzheimer's Drug Discovery Foundation
Pfizer
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
Keywords: preclinical Alzheimer's disease, blood exosomes
MeSH terms: Aged, Aged, 80 and over, Alzheimer Disease, Cross-Sectional Studies, Enzyme-Linked Immunosorbent Assay, Female, Humans, Male, Middle Aged, Peptide Fragments, Phosphorylation, Retrospective Studies, Severity of Illness Index, Time Factors, Biomarkers, Discriminant Analysis, Case-Control Studies, Amyloid beta-Peptides, tau Proteins, Exosomes, Frontotemporal Dementia, Prodromal Symptoms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case‐control study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks